Clément Kerneur

Clément Kerneur has extensive work experience in the field of biotechnology and research. Clément started their career at CRBM - CNRS UMR 5237 in 2011, where they worked as an Assistant Engineer and later as a Laboratory Technician, focusing on studying the biology of osteoclasts. During this time, they developed skills in molecular and cellular biology, animal experimentation, and histology.

In 2014, Clément joined Sanofi as a Biotechnology Engineer, where they were responsible for developing a method for therapeutic antibody dosage using mass spectrometry. Clément also qualified computerized standard equipment and validated ELISA dosage methods. Their role involved scientific monitoring, planning, internal communication, and presenting results. Clément gained experience working in a GLP environment.

In 2016, Clément returned to CRBM - CNRS UMR 5237 as a Study Engineer, working in the Tyrosine kinase and the cancer lab. Clément focused on studying the relationship between tyrosine kinase and cancer.

Currently, Clément is working at ImCheck Therapeutics as an R&D Scientist, starting in 2018. Their role involves contributing to research and development projects in the field of immunology.

Throughout their career, Clément has demonstrated strong scientific research skills, excellent communication abilities, and a thorough understanding of various laboratory techniques.

Clément Kerneur's education history includes the following:

From 2015 to 2016, Clément attended Pierre and Marie Curie University, where they pursued a Master 2 (M2) BMC specialization in Biothenologies with a focus on R&D Biotech. No specific field of study is mentioned.

In the year 2014 to 2015, Clément studied at École Pratique des Hautes Études, specializing in Biologie Santé Environnement with an option in SSIB. Their field of study was Infectiologie, which focuses on the study of infections.

From 2013 to 2014, Clément attended IUT Montpellier 2, where they completed a License Professionnelle in Biologie Analytique et Expérimentale, PharmacoGenomics, and Molecular Diagnostics.

Between 2011 and 2013, Clément studied at LEGTA St Genis LAVAL, pursuing a BTSA ANABIOTEC, focusing on Analyse Biologique et Biotechnologique.